Where does carmax stand on growth plans?

Who’s tipping what The week’s best shares ...

Investors have a lot to think about as the president’s policies gather momentum

Reaction suggests investors may no longer swayed by earnings ‘beats’

Wise had 9.8 million customers in the first quarter, up 17% year on year and 5% quarter-on-quarter

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Investors should consider shifting their focus to ‘old economy’ stocks rather than technology